华氏巨球蛋白血症的诊断:欧洲华氏巨球蛋白血症联盟共识声明
该共识由欧洲华氏巨球蛋白血症联盟(ECWM)制定,针对IgM相关淋巴浆细胞淋巴瘤(即华氏巨球蛋白血症,WM)的诊断挑战,提出了用于临床实践和研究/学术环境的共识建议与实验室要求。文件涵盖多参数流式细胞术、荧光原位杂交和分子检测的操作流程,旨在为意义未明的IgM单克隆丙种球蛋白病、无症状和有症状WM患者提供标准化诊断检查和 metodological 工作流程的指导。
要点
- ECWM发布WM诊断共识,涵盖临床实践与研究场景。
- 提供多参数流式细胞术、FISH和分子检测的操作流程。
- 指导意义未明的IgM单克隆丙种球蛋白病、无症状及有症状WM的标准化诊断。
核心结论
- ECWM制定WM诊断共识建议和实验室要求,适用于临床实践及研究/学术环境。
研究设计与样本
- 欧洲华氏巨球蛋白血症联盟(ECWM)制定的共识声明。
主要发现
- WM诊断因疾病表现多样而具有挑战性,近年诊断进展和对疾病生物学的深入理解影响了临床实践。
关键数值与推荐
- 提供多参数流式细胞术、荧光原位杂交和分子检测的操作流程。
- 为意义未明的IgM单克隆丙种球蛋白病、无症状和有症状WM患者提供标准化诊断检查和工作流程的指导。
临床怎么用
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The diagnosis of Waldenström's macroglobulinemia (WM), an IgM-associated lymphoplasmacytic lymphoma, can be challenging due to the different forms of disease presentation. Furthermore, in recent years, WM has witnessed remarkable progress on the diagnostic front, as well as a deeper understanding of the disease biology, which has affected clinical practice. This, together with the increasing variety of tools and techniques available, makes it necessary to have a practical guidance for clinicians to perform the initial evaluation of patients with WM. In this paper, we present the consensus recommendations and laboratory requirements for the diagnosis of WM developed by the European Consortium of Waldenström's Macroglobulinemia (ECWM), for both clinical practice as well as the research/academical setting. We provide the procedures for multiparametric flow cytometry, fluorescence in situ hybridization and molecular tests, and with this offer guidance for a standardized diagnostic work-up and methodological workflow of patients with IgM monoclonal gammopathy of uncertain significance, asymptomatic and symptomatic WM.
引用
- Dogliotti I, Jiménez C, Varettoni M, et al. Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia. Leukemia. 2022. PMID: 36435884. doi:10.1038/s41375-022-01762-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。